应用亚麻籽作为改善血脂曲线参数的有效方法:随机对照试验的最新系统回顾和荟萃分析

IF 2.4 Q3 NUTRITION & DIETETICS PharmaNutrition Pub Date : 2023-12-10 DOI:10.1016/j.phanu.2023.100366
Amir Hossein Moridpour , Masomeh Goodarzi , Zeynab Kavyani , Negarsadat Nademi , Maziar Daneshvar , Vali Musazadeh , Amir Hossein Faghfouri
{"title":"应用亚麻籽作为改善血脂曲线参数的有效方法:随机对照试验的最新系统回顾和荟萃分析","authors":"Amir Hossein Moridpour ,&nbsp;Masomeh Goodarzi ,&nbsp;Zeynab Kavyani ,&nbsp;Negarsadat Nademi ,&nbsp;Maziar Daneshvar ,&nbsp;Vali Musazadeh ,&nbsp;Amir Hossein Faghfouri","doi":"10.1016/j.phanu.2023.100366","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Numerous studies have shown the beneficial effects of flaxseed on lipid profile parameters; however, some others have reported contradictory results.</p></div><div><h3>Aim of the review</h3><p>The current study, therefore, aimed to provide a thorough understanding of the effects of flaxseed on lipid profile parameters in adults.</p></div><div><h3>Methods</h3><p>To this end, a comprehensive systematic search was conducted to collect the required trials from PubMed, Scopus<span><span>, Embase, </span>Cochrane Library, Web of Science databases, and Google Scholar up to December 2022.</span></p></div><div><h3>Results</h3><p>75 trials were included in our meta-analysis (two trials were only presented as a systematic review). Our study results indicated that the flaxseed supplementation significantly decreased the total levels of cholesterol (TC) (SMD: −0.57; 95% CI: −0.80, −0.33, <em>P</em><span> &lt; 0.001), triglyceride (TG) (SMD: −0.61; 95% CI: −0.87, −0.35, </span><em>P</em> &lt; 0.001), low-density lipoprotein-cholesterol (LDL-C) (SMD: −0.36; 95% CI: −0.61, −0.11; <em>P</em> = 0.005), and LDL-C/HDL-C ratios (SMD: −0.92, 95% CI: −1.35, −0.49, <em>P</em> &lt; 0.010). However, flaxseed did not change the levels of high-density lipoprotein-cholesterol (HDL-C) (SMD: 0.16; 95% CI: −0.03, 0.35, <em>P</em> = 0.097), and TC/HDL-C ratio (SMD: −0.35; 95% CI: −0.81, 0.11; <em>P</em> = 0.139).</p></div><div><h3>Conclusion</h3><p>It was concluded that the flaxseed supplementation may have improved the lipid profile. Therefore, it was recommended that flaxseed should be used as an adjuvant anti-hyperlipidemic agent.</p></div>","PeriodicalId":20049,"journal":{"name":"PharmaNutrition","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2023-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Application of flaxseed as an effective approach for improving lipid profile parameters: An updated systematic review and meta-analysis of randomized controlled trials\",\"authors\":\"Amir Hossein Moridpour ,&nbsp;Masomeh Goodarzi ,&nbsp;Zeynab Kavyani ,&nbsp;Negarsadat Nademi ,&nbsp;Maziar Daneshvar ,&nbsp;Vali Musazadeh ,&nbsp;Amir Hossein Faghfouri\",\"doi\":\"10.1016/j.phanu.2023.100366\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Numerous studies have shown the beneficial effects of flaxseed on lipid profile parameters; however, some others have reported contradictory results.</p></div><div><h3>Aim of the review</h3><p>The current study, therefore, aimed to provide a thorough understanding of the effects of flaxseed on lipid profile parameters in adults.</p></div><div><h3>Methods</h3><p>To this end, a comprehensive systematic search was conducted to collect the required trials from PubMed, Scopus<span><span>, Embase, </span>Cochrane Library, Web of Science databases, and Google Scholar up to December 2022.</span></p></div><div><h3>Results</h3><p>75 trials were included in our meta-analysis (two trials were only presented as a systematic review). Our study results indicated that the flaxseed supplementation significantly decreased the total levels of cholesterol (TC) (SMD: −0.57; 95% CI: −0.80, −0.33, <em>P</em><span> &lt; 0.001), triglyceride (TG) (SMD: −0.61; 95% CI: −0.87, −0.35, </span><em>P</em> &lt; 0.001), low-density lipoprotein-cholesterol (LDL-C) (SMD: −0.36; 95% CI: −0.61, −0.11; <em>P</em> = 0.005), and LDL-C/HDL-C ratios (SMD: −0.92, 95% CI: −1.35, −0.49, <em>P</em> &lt; 0.010). However, flaxseed did not change the levels of high-density lipoprotein-cholesterol (HDL-C) (SMD: 0.16; 95% CI: −0.03, 0.35, <em>P</em> = 0.097), and TC/HDL-C ratio (SMD: −0.35; 95% CI: −0.81, 0.11; <em>P</em> = 0.139).</p></div><div><h3>Conclusion</h3><p>It was concluded that the flaxseed supplementation may have improved the lipid profile. Therefore, it was recommended that flaxseed should be used as an adjuvant anti-hyperlipidemic agent.</p></div>\",\"PeriodicalId\":20049,\"journal\":{\"name\":\"PharmaNutrition\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2023-12-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PharmaNutrition\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213434423000385\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"NUTRITION & DIETETICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PharmaNutrition","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213434423000385","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

摘要

背景大量研究表明亚麻籽对血脂指标有益处;但也有一些研究报告了相互矛盾的结果。方法为此,我们进行了全面的系统检索,从 PubMed、Scopus、Embase、Cochrane Library、Web of Science 数据库和谷歌学术中收集了截至 2022 年 12 月的所需试验。我们的研究结果表明,补充亚麻籽可显著降低总胆固醇(TC)水平(SMD:-0.57;95% CI:-0.80,-0.33,P < 0.001)、甘油三酯(TG)水平(SMD:-0.61;95% CI:-0.87,-0.35,P <;0.001)、低密度脂蛋白胆固醇(LDL-C)(SMD:-0.36;95% CI:-0.61,-0.11;P = 0.005)和 LDL-C/HDL-C 比率(SMD:-0.92,95% CI:-1.35,-0.49,P <;0.010)。然而,亚麻籽并未改变高密度脂蛋白胆固醇(HDL-C)水平(SMD:0.16;95% CI:-0.03,0.35,P = 0.097)和 TC/HDL-C 比率(SMD:-0.35;95% CI:-0.81,0.11;P = 0.139)。因此,建议将亚麻籽用作辅助抗高血脂药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Application of flaxseed as an effective approach for improving lipid profile parameters: An updated systematic review and meta-analysis of randomized controlled trials

Background

Numerous studies have shown the beneficial effects of flaxseed on lipid profile parameters; however, some others have reported contradictory results.

Aim of the review

The current study, therefore, aimed to provide a thorough understanding of the effects of flaxseed on lipid profile parameters in adults.

Methods

To this end, a comprehensive systematic search was conducted to collect the required trials from PubMed, Scopus, Embase, Cochrane Library, Web of Science databases, and Google Scholar up to December 2022.

Results

75 trials were included in our meta-analysis (two trials were only presented as a systematic review). Our study results indicated that the flaxseed supplementation significantly decreased the total levels of cholesterol (TC) (SMD: −0.57; 95% CI: −0.80, −0.33, P < 0.001), triglyceride (TG) (SMD: −0.61; 95% CI: −0.87, −0.35, P < 0.001), low-density lipoprotein-cholesterol (LDL-C) (SMD: −0.36; 95% CI: −0.61, −0.11; P = 0.005), and LDL-C/HDL-C ratios (SMD: −0.92, 95% CI: −1.35, −0.49, P < 0.010). However, flaxseed did not change the levels of high-density lipoprotein-cholesterol (HDL-C) (SMD: 0.16; 95% CI: −0.03, 0.35, P = 0.097), and TC/HDL-C ratio (SMD: −0.35; 95% CI: −0.81, 0.11; P = 0.139).

Conclusion

It was concluded that the flaxseed supplementation may have improved the lipid profile. Therefore, it was recommended that flaxseed should be used as an adjuvant anti-hyperlipidemic agent.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
PharmaNutrition
PharmaNutrition Agricultural and Biological Sciences-Food Science
CiteScore
5.70
自引率
3.10%
发文量
33
审稿时长
12 days
期刊最新文献
Advancements in psoriasis management: Integrating nutrient supplement with gut-brain-skin connection Can L-Methionine and S-Adenosyl-L-Methionine Effectively Mitigate Scopolamine-Induced Cognitive and Motor Deficits in Mice? Melatonin supplementation in preclinical colitis models: A systematic review and dose-response meta-analysis on inflammation, oxidative stress, and colon repair Efficacy and safety of liraglutide on C-reactive protein (CRP) in adults with type 2 diabetes: A GRADE-assessed systematic review and dose-response meta-analysis of controlled trials Editorial Board
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1